140 related articles for article (PubMed ID: 656224)
1. Anticoagulants and the Björk-Shiley prosthesis. Experience of 390 patients.
Sutton MG; Miller GA; Oldershaw PJ; Paneth M
Br Heart J; 1978 May; 40(5):558-62. PubMed ID: 656224
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Weinstein GS; Mavroudis C; Ebert PA
Ann Thorac Surg; 1982 Jun; 33(6):549-53. PubMed ID: 6178379
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy in children with left-sided mechanical prostheses.
LeBlanc JG; Sett SS; Vince DJ
Eur J Cardiothorac Surg; 1993; 7(4):211-5. PubMed ID: 8481259
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
5. Management of thrombo-embolism after aortic valve replacement with the Björk-Shiley tilting disc valve. Medicamental prevention with dicumarol in comparison with dipyridamole - acetylsalicylic acid. Surgical treatment of prosthetic thrombosis.
Björk VO; Henze A
Scand J Thorac Cardiovasc Surg; 1975; 9(3):183-91. PubMed ID: 54935
[TBL] [Abstract][Full Text] [Related]
6. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
7. Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement.
Hassouna A; Allam H; Awad A; Hassaballah F
Cardiovasc Surg; 2000 Oct; 8(6):491-8. PubMed ID: 10996106
[TBL] [Abstract][Full Text] [Related]
8. The choice of anticoagulation in pediatric patients with the St. Jude Medical valve prostheses.
Serra AJ; McNicholas KW; Olivier HF; Boe SL; Lemole GM
J Cardiovasc Surg (Torino); 1987; 28(5):588-91. PubMed ID: 3654744
[TBL] [Abstract][Full Text] [Related]
9. Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years.
Milano AD; Bortolotti U; Mazzucco A; Guerra F; Magni A; Gallucci V
J Thorac Cardiovasc Surg; 1989 Jul; 98(1):37-47. PubMed ID: 2739424
[TBL] [Abstract][Full Text] [Related]
10. Late results of valve replacement with the Björk-Shiley valve (1973 to 1982).
Orszulak TA; Schaff HV; DeSmet JM; Danielson GK; Pluth JR; Puga FJ
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):302-12. PubMed ID: 8429659
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulants and the Björk-Shiley prosthesis.
Rajah SM; Rao S; Watson DA
Br Heart J; 1979 Sep; 42(3):364-5. PubMed ID: 508462
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of a new anticoagulant therapy in prosthetic valve replacement.
Sakashita I; Ohtani S; Nakamura C; Washio M
Jpn Heart J; 1978 May; 19(3):324-31. PubMed ID: 29142
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
Sullivan JM; Harken DE; Gorlin R
N Engl J Med; 1971 Jun; 284(25):1391-4. PubMed ID: 4931099
[No Abstract] [Full Text] [Related]
14. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.
Sullivan JM; Harken DE; Gorlin R
N Engl J Med; 1968 Sep; 279(11):576-80. PubMed ID: 5667468
[No Abstract] [Full Text] [Related]
15. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
[TBL] [Abstract][Full Text] [Related]
16. [Short- and mean results of mitral and aortic valve replacement with a Björk-Shiley disc prosthesis. Thromboembolic and hemorrhagic complications].
Soots G; Stankowiak C; Pommier J; Warembourg HE; Watel AA
Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1187-95. PubMed ID: 121522
[TBL] [Abstract][Full Text] [Related]
17. [Late complications following Björk-Shiley and St. Jude Medical heart valve replacement].
Horstkotte D; Körfer R; Budde T; Haerten K; Schulte HD; Bircks W; Loogen F
Z Kardiol; 1983 May; 72(5):251-61. PubMed ID: 6880335
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinical results with Omniscience (STM1), Medtronic-Hall, and Björk-Shiley convexo-concave (70 degrees) prostheses in mitral valve replacement.
Cortina JM; Martinell J; Artiz V; Fraile J; Rábago G
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):174-83. PubMed ID: 3945084
[TBL] [Abstract][Full Text] [Related]
19. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized study of St Jude Medical versus Björk-Shiley or Starr-Edwards 6120 valve prostheses in the mitral position. Three hundred and fifty-seven patients operated on from 1979 to December 1983.
Mikaeloff P; Jegaden O; Ferrini M; Coll-Mazzei J; Bonnefoy JY; Rumolo A
J Cardiovasc Surg (Torino); 1989; 30(6):966-75. PubMed ID: 2600130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
